Hengrui Medicine: Zhu Guoxin appointed as Senior Vice President of the company.

Hengrui Medicine announced that Zhu Guoxin has been appointed as Senior Vice President of the company. Zhu Guoxin has over 30 years of global cross-functional experience in drug discovery, covering various stages from target hypothesis to early clinical testing, involving multiple disease areas such as diabetes/obesity and its complications, immunology, neurologic diseases, pain, and oncology. Prior to joining the company, Zhu Guoxin served as Vice President at Eli Lilly's New Drug Research Center, leading multiple discovery research and early development projects, serving as Chair of the Small Molecule Strategy Group, supervising the research and delivery of over 100 small molecule clinical candidates.